Treace Medical Concepts (TMCI) Operating Margin (2020 - 2026)
Treace Medical Concepts (TMCI) reported Operating Margin of 36.37% for Q1 2026, down 673.0% on a YoY basis from 6.35% in Q1 2025, and down 283.99% quarter-over-quarter from 9.47% in Q4 2025.
Treace Medical Concepts (TMCI) Operating Margin (2020 - 2026) Analysis & Trends
Treace Medical Concepts has reported Operating Margin for 7 years, with the latest figure at 36.37% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 673.0% year-over-year to 36.37%; the trailing twelve-month figure through Mar 2026 stood at 26.89% (down 208.0% YoY), and the FY2025 full-year result was 25.46%, up 114.0% from the prior year.
- Operating Margin for Q1 2026 stood at 36.37%, down from 9.47% in the prior quarter.
- The five-year high for Operating Margin was 0.3% in Q4 2024, with the low at 48.1% in Q2 2024.
- Historically, Operating Margin has averaged 28.76% across 5 years, with a median of 32.65% in 2023.
- Annual changes were most pronounced in 2022 — Operating Margin tumbled 2038 bps — and 2025, when it soared 1228 bps.
- Treace Medical Concepts' Operating Margin stood at 7.03% in 2022, then sank by 55 bps to 10.9% in 2023, then soared by 97 bps to 0.3% in 2024, then sank by 3090 bps to 9.47% in 2025, then plunged by 284 bps to 36.37% in 2026.
- The last three Operating Margin figures came in at 36.37% (Q1 2026), 9.47% (Q4 2025), and 31.22% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Treace Medical Concepts | 274.20 Mn | 222.34 Mn | 37.41 Mn | -36.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.37% |
| Dec 31, 2025 | -9.47% |
| Sep 30, 2025 | -31.22% |
| Jun 30, 2025 | -35.82% |
| Mar 31, 2025 | -29.64% |
| Dec 31, 2024 | -0.30% |
| Sep 30, 2024 | -33.57% |
| Jun 30, 2024 | -48.10% |
| Mar 31, 2024 | -37.11% |
| Dec 31, 2023 | -10.90% |
| Sep 30, 2023 | -43.72% |
| Jun 30, 2023 | -31.11% |
| Mar 31, 2023 | -32.65% |
| Dec 31, 2022 | -7.03% |
| Sep 30, 2022 | -34.24% |
| Jun 30, 2022 | -39.82% |
| Mar 31, 2022 | -27.87% |
| Dec 31, 2021 | -16.74% |
| Sep 30, 2021 | -25.26% |
| Jun 30, 2021 | -19.61% |